Why should cannabis professionals attend Latin America’s largest cannabis event?
ExpoCannabis Brasil 2026 returns for its 4th edition in November, bringing together over 45,000 attendees from 14+ countries at Sao Paulo Expo. As the franchise extension of Uruguay’s pioneering ExpoCannabis (the country that became the first in the world to fully legalize cannabis in 2013), this event represents LATAM’s most significant convergence of cannabis culture, business, and medicine.
Brazil’s medical cannabis market now serves 672,000 patients and generates $349 million annually, making it the largest medical cannabis market in Latin America. With 2026 marked as the “decisive year” for domestic cultivation legislation and significant ANVISA regulatory updates pending, this conference arrives at a pivotal moment for the entire region.
“
45,000+ expected attendees, representing 114% growth over four editions since 2023.
Whether you’re seeking Brazilian pharmaceutical partnerships, exploring LATAM market entry, or evaluating seed-to-sale technology for ANVISA compliance, ExpoCannabis Brasil brings together the decision-makers shaping the future of Latin American cannabis operations under one roof.
ExpoCannabis Brasil 2026 at a Glance 🇧🇷
Dates November 20-22, 2026
Location Sao Paulo Expo (Pavilions 7 & 8), Sao Paulo, Brazil
Expected Attendance 45,000+ visitors from 14+ countries
Exhibition Space 20,000 sqm with 300+ exhibitors
Audience Type B2B + Consumer (mixed)
Official Website expocannabisbrasil.com
Confirmed Last verified: January 3, 2026
Sao Paulo
23.55°S 46.63°W Who Should Attend ExpoCannabis Brasil 2026
ExpoCannabis Brasil attracts decision-makers across the cannabis supply chain who are evaluating LATAM market entry or seeking to expand existing operations in Brazil’s rapidly growing medical cannabis sector.
Cannabis business investors seeking LATAM market opportunities
International brands entering Brazilian markets via partnerships
Medical researchers and clinicians exploring Brazilian protocols
Cultivation and extraction specialists preparing for domestic licensing
Policy advocates and NGOs active in cannabis reform
Cultural and lifestyle industry professionals
Why ExpoCannabis Brasil Matters in 2026
ExpoCannabis Brasil has demonstrated remarkable expansion across its editions: from 21,000 attendees in 2022 to 40,000 in 2023, 42,000 in 2024, and now projecting 45,000+ for 2026. This 114% growth over four editions reflects Brazil’s rapidly expanding cannabis ecosystem.
The 2026 edition arrives after several regulatory milestones. Domestic cultivation bill PL 399/2015 awaits plenary vote with 2026 marked as the “decisive year.” ANVISA’s public consultation on RDC 327 revisions brings new administration routes and compounding pharmacy authorization. The June 2024 STF decriminalization ruling has had over a year to reshape market dynamics.
Brazil’s medical cannabis market serves 672,000 patients with 56% year-over-year growth, generating $349 million annually and projected to grow at 24.6% CAGR through 2030.
Kaya Mind Yearbook & Cognitive Market Research, 2025Planning Your ExpoCannabis Brasil 2026 Trip
Whether you’re attending for the first time or returning to expand your LATAM network, these practical tips will help you maximize your conference experience.
Accommodation
- Book 8-12 weeks in advance – with 45,000+ attendees, major hotel blocks fill quickly
- Hotels near Rodovia dos Imigrantes and Jabaquara district offer proximity to venue
- Blue Tree Towers Morumbi and similar business hotels provide reliable options
- Central Sao Paulo (Jardins, Paulista) offers more dining but expect 45-60 min commutes
Schedule Overview
- Day 1 (Nov 20): Exhibition opening, Cannabis Business Hub networking
- Day 2 (Nov 21): Dr. Elisaldo Carlini Scientific Congress sessions
- Day 3 (Nov 22): International Forum, closing ceremonies
- Secure CBH premium passes early for curated B2B networking
Getting There
- Guarulhos International (GRU) is main hub, ~40 km from Sao Paulo Expo
- Congonhas Airport (CGH) handles domestic flights, closer to venue
- Uber and 99 (local rideshare) operate extensively throughout Sao Paulo
- Venue provides shuttle services from key locations during major events
Budget-Conscious Options
- Solidarity tickets: 50% discount with food donations (25-ton collective goal)
- R$ 315 for 3-day solidarity pass vs R$ 630 full price (2025 reference)
- Basic Portuguese significantly improves networking opportunities
- Business cards in Portuguese demonstrate cultural respect
Understanding Brazil’s Cannabis Regulatory Landscape
Key Regulatory Topics at ExpoCannabis Brasil
- RDC 327/2019: Governs manufacturing and importing of cannabis products with <0.2% thc requirement
- RDC 660/2022: Enables individual patient imports with ANVISA registration, serving 47% of patients
- ANVISA Authorization: Foreign companies must partner with Brazilian pharmaceutical companies holding sanitary authorization
- Domestic Cultivation Bill (PL 399/2015): Approved by Special Commission in 2021, awaiting plenary vote in 2026
Brazil operates LATAM’s largest medical cannabis market under a unique import-dependent model. Unlike markets with domestic cultivation, Brazil prohibits cannabis growing – the market operates entirely through imports and patient associations. Over 500 companies now export to Brazil, led by USA, Canada, Colombia, Uruguay, Netherlands, and Spain. For official regulatory updates, visit ANVISA’s official portal.
Related: Cannabis Cultivation Software🇧🇷 Brazil’s Medical Cannabis Market: From Uruguay’s Blueprint to LATAM Leadership
ExpoCannabis Brasil carries special significance as a franchise of ExpoCannabis Uruguay, the event from the first country to fully legalize cannabis in 2013. This connection highlights the evolution of cannabis policy across Latin America and Brazil’s emergence as the region’s dominant medical market.
Key Facts for ExpoCannabis Brasil Attendees
- ✓ 672,000 Patients: Brazil’s medical cannabis system now serves over 672,000 patients with 56% YoY growth
- ✓ $349 Million Market: Annual market value with 24.6% CAGR projected through 2030
- ✓ 80%+ Municipal Coverage: Cannabis product access now available in over 80% of Brazilian municipalities
- ✓ 7,000+ Habeas Corpus: Court decisions granting cultivation rights to individual patients
- ✓ 2,180+ Products: Cannabis-based products available in market, ~600 through import channels
- ✓ STF Decriminalization: June 2024 ruling allows up to 40g possession and home cultivation of 6 plants
Did You Know?
Uruguay became the first country in the world to fully legalize cannabis in December 2013 under President Jose Mujica. ExpoCannabis Brasil operates as a franchise of the original Uruguayan event, symbolically connecting Brazil’s emerging market to LATAM’s legalization pioneer. This Uruguay-Brazil axis represents the two largest economies in the Mercosur trading bloc.
Actionable Insight for Investors
Brazil’s import-dependent model creates unique opportunities. International exporters can access a 672,000-patient market without local manufacturing. If domestic cultivation passes (PL 399/2015), early movers establishing Brazilian partnerships now will be positioned for local production licensing. ANVISA’s March 2026 deadline for cultivation regulation response means significant clarity before ExpoCannabis Brasil’s November dates.
Note: Laws and enforcement can change. This information is for educational purposes only.
Operational Challenges Facing Brazilian Cannabis Operators
Cannabis businesses entering the Brazilian market encounter operational complexities that require significant planning and partnership development. Conference attendees frequently discuss these common challenges:
-
Mandatory Local Partnerships
Foreign companies cannot register products directly in Brazil – partnerships with Brazilian pharmaceutical companies holding ANVISA authorization are required
-
Import-Dependent Supply Chain
With domestic cultivation prohibited, all products must be imported, creating logistics and cost challenges for market scaling
-
ANVISA Documentation Requirements
Sanitary authorization valid for 5 years requires comprehensive documentation and GMP certification for manufacturers
-
Multi-Channel Market Access
Navigating three distinct patient access channels (imports, pharmacy products, patient associations) each with different regulatory requirements
What to Prepare Before ExpoCannabis Brasil 2026
Maximize your conference ROI by arriving prepared. Use this checklist to ensure you’re ready to make the most of every networking opportunity and business meeting.
Documents to Bring
- Business cards (Portuguese and English versions)
- Company capability presentations translated to Portuguese
- GMP certification documentation (for manufacturers)
- Investment thesis materials (for CBH networking)
- Import/export compliance documentation samples
- Regulatory consultant contact list
Questions to Ask Partners
- What ANVISA authorizations do you currently hold?
- What is your product registration capacity for international brands?
- What distribution network do you have across Brazilian states?
- What is the timeline for domestic cultivation legislation impact?
- How are you positioning for RDC 327 revision outcomes?
- What patient access expansion strategies are you pursuing?
What to Compare
- Franchise opportunities in Uruguay-Brazil corridor
- Distribution partners serving 80%+ municipal coverage
- Brazilian pharma companies with ANVISA authorizations
- Patient association networks (147,000+ members)
- Compounding pharmacy partnerships for CBD authorization
- Embrapa hemp research applications
Frequently Asked Questions
Common questions from cannabis professionals planning to attend ExpoCannabis Brasil.
Is ExpoCannabis Brasil B2B only?
No. ExpoCannabis Brasil serves both business and consumer audiences. The event maintains its cultural roots as a cannabis fair while offering premium B2B programming through the Cannabis Business Hub (CBH). General admission provides access to the exhibition floor and many educational sessions.
What are solidarity tickets?
ExpoCannabis Brasil offers 50% discounted tickets for attendees who donate food items. The 2026 edition aims to collect 25 tons of food for social causes. This program reflects the event’s community orientation and offers budget-conscious attendance options.
How international is the event?
Very international. ExpoCannabis Brasil 2026 expects representatives from 14+ countries. As LATAM’s largest cannabis event, it draws significant attendance from throughout South America, North America, and Europe. The event is branded as “Latinnabis Americas” for 2026.
How do I access the Cannabis Business Hub (CBH)?
CBH requires premium registration beyond general admission. This track offers curated B2B networking, pre-scheduled meetings, and investor matchmaking services. Registration typically opens several months before the event. Secure CBH access early as spaces are limited.
What is the Dr. Elisaldo Carlini Scientific Congress?
Named after Dr. Elisaldo Carlini (1930-2020), a Brazilian physician who pioneered cannabis research in Brazil, this congress runs alongside the exhibition. It features scientific presentations, clinical case studies, and research updates from Brazilian and international researchers.
Can I consume cannabis at the event?
Brazil has decriminalized possession up to 40 grams and permits home cultivation of up to 6 plants per STF June 2024 ruling. However, consumption policies at Sao Paulo Expo should be confirmed with event organizers. Generally, cannabis consumption remains restricted in public venues.
Software Solutions for Brazilian Cannabis Compliance
For companies entering Brazil’s medical cannabis market or expanding existing operations, compliance software designed for regulated cannabis environments provides essential infrastructure. GrowerIQ’s seed-to-sale tracking platform supports the traceability requirements central to ANVISA authorization.
Key capabilities include lot tracking from import/manufacture through dispensing, SNGPC (Sistema Nacional de Gerenciamento de Produtos Controlados) reporting compatibility, GMP documentation workflows for ANVISA inspections, and multi-language interface supporting Portuguese operations.
Ready to Simplify Your Cannabis Compliance?
See how cannabis facilities in Latin America use GrowerIQ to manage seed-to-sale traceability and regulatory reporting.
Request Demo
About GrowerIQ
GrowerIQ is a complete cannabis production management platform. Ours is the first platform to integrate your facility systems, including sensors, building controls, QMS, and ERP, into a single simplified interface.
GrowerIQ is changing the way producers use software - transforming a regulatory requirement into a robust platform to learn, analyze, and improve performance.
To find out more about GrowerIQ and how we can help, fill out the form to the right, start a chat, or contact us.
GrowerIQ is changing the way producers use software - transforming a regulatory requirement into a robust platform to learn, analyze, and improve performance.
To find out more about GrowerIQ and how we can help, fill out the form to the right, start a chat, or contact us.